skip to main content
TFRI News | January 15, 2015

Congratulations to TFRI researcher on $25 million funding for cancer biotherapeutics initiative

The Terry Fox Research Institute congratulates Dr. John Bell and his team on their award of $25 million in funding from the Government of Canada's Networks of Centres of Excellence. Dr. Bell will launch Biotherapeutics for Cancer Treatment (BioCanRx), a new national initiative to move promising cancer biotherapeutics, such as cancer-killing viruses and immune cell therapies, from discovery to clinical trials.

Dr. John Bell is a senior scientist at the Ottawa Hospital Research Institute (OHRI) and Project Leader on the Terry Fox New Frontiers Program Project Grant: Canadian Oncolytic Virus Consortium.

Darrell Fox, senior advisor to TFRI and brother of Terry Fox, will serve on the board of BioCanRx.


More information on Dr. Bell's TFRI research

Read about Dr. Bell's TFRI-funded research in the TFRI Annual Report.

Watch Dr. Bell talk about the Canadian Oncolytic Virus Consortium

More information on BioCanRx

The news announcement from the Government of Canada.
The news release from the Ottawa Hospital Research Institute.